Annual EBITDA
$10.33 B
+$1.66 B+19.22%
31 December 2023
Summary:
Eli Lilly and Company annual earnings before interest, taxes, depreciation & amortization is currently $10.33 billion, with the most recent change of +$1.66 billion (+19.22%) on 31 December 2023. During the last 3 years, it has risen by +$1.41 billion (+15.84%). LLY annual EBITDA is now at all-time high.LLY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$2.25 B
-$1.87 B-45.38%
30 September 2024
Summary:
Eli Lilly and Company quarterly earnings before interest, taxes, depreciation & amortization is currently $2.25 billion, with the most recent change of -$1.87 billion (-45.38%) on 30 September 2024. Over the past year, it has increased by +$1.29 billion (+133.48%). LLY quarterly EBITDA is now -45.38% below its all-time high of $4.12 billion, reached on 30 June 2024.LLY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$12.51 B
+$1.29 B+11.44%
30 September 2024
Summary:
Eli Lilly and Company TTM earnings before interest, taxes, depreciation & amortization is currently $12.51 billion, with the most recent change of +$1.29 billion (+11.44%) on 30 September 2024. Over the past year, it has increased by +$4.43 billion (+54.71%). LLY TTM EBITDA is now at all-time high.LLY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.2% | +133.5% | +54.7% |
| 3 y3 years | +15.8% | +31.4% | +45.5% |
| 5 y5 years | +86.7% | +24.8% | +104.0% |
LLY EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.4% | -45.4% | +133.5% | at high | +55.6% |
| 5 y | 5 years | at high | +86.7% | -45.4% | +133.5% | at high | +104.0% |
| alltime | all time | at high | >+9999.0% | -45.4% | +175.6% | at high | +6252.5% |
Eli Lilly And Company EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.25 B(-45.4%) | $12.51 B(+11.4%) |
| June 2024 | - | $4.12 B(+32.1%) | $11.23 B(+15.9%) |
| Mar 2024 | - | $3.12 B(+2.7%) | $9.69 B(+13.1%) |
| Dec 2023 | $10.33 B(+19.2%) | $3.03 B(+215.2%) | $8.57 B(+5.9%) |
| Sept 2023 | - | $962.80 M(-62.6%) | $8.09 B(-11.5%) |
| June 2023 | - | $2.58 B(+29.1%) | $9.14 B(+13.0%) |
| Mar 2023 | - | $1.99 B(-21.9%) | $8.08 B(-6.7%) |
| Dec 2022 | $8.66 B(+7.7%) | $2.56 B(+27.1%) | $8.66 B(+2.2%) |
| Sept 2022 | - | $2.01 B(+32.1%) | $8.47 B(+3.7%) |
| June 2022 | - | $1.52 B(-40.9%) | $8.17 B(-6.1%) |
| Mar 2022 | - | $2.57 B(+8.8%) | $8.70 B(+8.2%) |
| Dec 2021 | $8.04 B(-9.8%) | $2.37 B(+38.3%) | $8.04 B(-6.5%) |
| Sept 2021 | - | $1.71 B(-16.5%) | $8.60 B(-2.0%) |
| June 2021 | - | $2.05 B(+7.1%) | $8.78 B(-0.1%) |
| Mar 2021 | - | $1.91 B(-34.6%) | $8.78 B(-1.5%) |
| Dec 2020 | $8.91 B(+29.2%) | $2.93 B(+55.2%) | $8.91 B(+10.2%) |
| Sept 2020 | - | $1.89 B(-8.3%) | $8.09 B(+1.0%) |
| June 2020 | - | $2.06 B(+0.5%) | $8.00 B(+3.0%) |
| Mar 2020 | - | $2.05 B(-2.6%) | $7.77 B(+12.6%) |
| Dec 2019 | $6.90 B(+24.7%) | $2.10 B(+16.6%) | $6.90 B(+12.5%) |
| Sept 2019 | - | $1.80 B(-1.3%) | $6.13 B(-0.3%) |
| June 2019 | - | $1.82 B(+55.4%) | $6.15 B(+26.6%) |
| Mar 2019 | - | $1.17 B(-12.0%) | $4.86 B(-12.2%) |
| Dec 2018 | $5.53 B(+35.0%) | $1.33 B(-26.6%) | $5.53 B(+9.2%) |
| Sept 2018 | - | $1.82 B(+242.8%) | $5.06 B(+18.5%) |
| June 2018 | - | $530.20 M(-71.3%) | $4.27 B(-21.6%) |
| Mar 2018 | - | $1.85 B(+113.5%) | $5.45 B(+33.1%) |
| Dec 2017 | $4.10 B(-19.0%) | $866.30 M(-15.6%) | $4.10 B(-9.3%) |
| Sept 2017 | - | $1.03 B(-40.0%) | $4.52 B(-7.8%) |
| June 2017 | - | $1.71 B(+245.6%) | $4.90 B(+7.6%) |
| Mar 2017 | - | $494.70 M(-61.6%) | $4.55 B(-9.9%) |
| Dec 2016 | $5.06 B(+15.5%) | $1.29 B(-8.7%) | $5.06 B(+9.9%) |
| Sept 2016 | - | $1.41 B(+3.6%) | $4.60 B(-0.7%) |
| June 2016 | - | $1.36 B(+36.7%) | $4.63 B(+6.3%) |
| Mar 2016 | - | $995.70 M(+19.6%) | $4.36 B(-0.5%) |
| Dec 2015 | $4.38 B(-3.3%) | $832.20 M(-42.4%) | $4.38 B(-1.3%) |
| Sept 2015 | - | $1.45 B(+33.2%) | $4.44 B(+10.2%) |
| June 2015 | - | $1.08 B(+6.8%) | $4.03 B(-5.6%) |
| Mar 2015 | - | $1.02 B(+14.1%) | $4.27 B(-5.8%) |
| Dec 2014 | $4.53 B(-39.6%) | $890.40 M(-14.1%) | $4.53 B(-8.3%) |
| Sept 2014 | - | $1.04 B(-21.8%) | $4.94 B(-14.9%) |
| June 2014 | - | $1.32 B(+3.7%) | $5.80 B(-9.3%) |
| Mar 2014 | - | $1.28 B(-1.8%) | $6.40 B(-14.6%) |
| Dec 2013 | $7.50 B(+6.3%) | $1.30 B(-31.6%) | $7.50 B(-1.3%) |
| Sept 2013 | - | $1.90 B(-0.9%) | $7.59 B(-4.9%) |
| June 2013 | - | $1.92 B(-19.1%) | $7.98 B(+4.3%) |
| Mar 2013 | - | $2.37 B(+69.5%) | $7.65 B(+8.6%) |
| Dec 2012 | $7.05 B(+2.0%) | $1.40 B(-38.9%) | $7.05 B(-0.2%) |
| Sept 2012 | - | $2.29 B(+44.0%) | $7.06 B(+5.8%) |
| June 2012 | - | $1.59 B(-10.0%) | $6.67 B(-4.9%) |
| Mar 2012 | - | $1.77 B(+25.2%) | $7.01 B(+1.5%) |
| Dec 2011 | $6.91 B(-14.1%) | $1.41 B(-26.0%) | $6.91 B(-5.2%) |
| Sept 2011 | - | $1.91 B(-1.4%) | $7.29 B(-2.1%) |
| June 2011 | - | $1.93 B(+16.3%) | $7.45 B(-2.6%) |
| Mar 2011 | - | $1.66 B(-7.3%) | $7.64 B(-4.9%) |
| Dec 2010 | $8.04 B(+16.2%) | $1.79 B(-13.2%) | $8.04 B(+2.9%) |
| Sept 2010 | - | $2.06 B(-3.1%) | $7.81 B(+8.7%) |
| June 2010 | - | $2.13 B(+3.6%) | $7.19 B(+4.2%) |
| Mar 2010 | - | $2.05 B(+31.4%) | $6.89 B(-0.3%) |
| Dec 2009 | $6.92 B(>+9900.0%) | $1.56 B(+8.7%) | $6.92 B(+190.8%) |
| Sept 2009 | - | $1.44 B(-21.7%) | $2.38 B(+129.9%) |
| June 2009 | - | $1.84 B(-11.5%) | $1.03 B(+42.3%) |
| Mar 2009 | - | $2.08 B(-169.8%) | $727.00 M(+1579.0%) |
| Dec 2008 | $43.30 M(-99.3%) | -$2.98 B(-3248.4%) | $43.30 M(-99.0%) |
| Sept 2008 | - | $94.50 M(-93.8%) | $4.50 B(-23.5%) |
| June 2008 | - | $1.53 B(+9.8%) | $5.88 B(+0.3%) |
| Mar 2008 | - | $1.39 B(-6.0%) | $5.87 B(+0.3%) |
| Dec 2007 | $5.85 B(+18.7%) | $1.48 B(+0.5%) | $5.85 B(+4.5%) |
| Sept 2007 | - | $1.48 B(-2.6%) | $5.60 B(+3.9%) |
| June 2007 | - | $1.52 B(+10.0%) | $5.39 B(+6.2%) |
| Mar 2007 | - | $1.38 B(+11.9%) | $5.08 B(+3.0%) |
| Dec 2006 | $4.93 B(+12.6%) | $1.23 B(-2.6%) | $4.93 B(+0.5%) |
| Sept 2006 | - | $1.26 B(+5.1%) | $4.90 B(+3.1%) |
| June 2006 | - | $1.20 B(-2.2%) | $4.76 B(+3.4%) |
| Mar 2006 | - | $1.23 B(+1.9%) | $4.60 B(+5.1%) |
| Dec 2005 | $4.38 B(+2.8%) | $1.21 B(+8.0%) | $4.38 B(+2.2%) |
| Sept 2005 | - | $1.12 B(+6.8%) | $4.28 B(+2.2%) |
| June 2005 | - | $1.05 B(+4.2%) | $4.19 B(-0.2%) |
| Mar 2005 | - | $1.00 B(-9.6%) | $4.20 B(-1.4%) |
| Dec 2004 | $4.26 B | $1.11 B(+8.3%) | $4.26 B(+2.8%) |
| Sept 2004 | - | $1.03 B(-2.7%) | $4.14 B(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $1.06 B(-0.6%) | $4.20 B(+1.3%) |
| Mar 2004 | - | $1.06 B(+6.6%) | $4.14 B(+2.3%) |
| Dec 2003 | $4.05 B(+6.0%) | $996.40 M(-7.9%) | $4.05 B(+0.1%) |
| Sept 2003 | - | $1.08 B(+7.8%) | $4.05 B(+1.4%) |
| June 2003 | - | $1.00 B(+3.6%) | $3.99 B(+2.1%) |
| Mar 2003 | - | $968.60 M(-2.4%) | $3.91 B(+2.3%) |
| Dec 2002 | $3.82 B(-8.7%) | $992.40 M(-3.2%) | $3.82 B(+3.4%) |
| Sept 2002 | - | $1.03 B(+11.3%) | $3.70 B(+0.1%) |
| June 2002 | - | $920.90 M(+4.4%) | $3.69 B(-6.4%) |
| Mar 2002 | - | $882.30 M(+1.7%) | $3.95 B(-5.7%) |
| Dec 2001 | $4.18 B(+4.7%) | $867.20 M(-15.2%) | $4.18 B(-3.1%) |
| Sept 2001 | - | $1.02 B(-12.9%) | $4.32 B(-2.6%) |
| June 2001 | - | $1.18 B(+5.0%) | $4.43 B(+5.4%) |
| Mar 2001 | - | $1.12 B(+12.1%) | $4.20 B(+5.2%) |
| Dec 2000 | $4.00 B(+5.1%) | $999.00 M(-12.2%) | $4.00 B(-1.7%) |
| Sept 2000 | - | $1.14 B(+20.2%) | $4.07 B(+3.2%) |
| June 2000 | - | $946.80 M(+3.8%) | $3.94 B(+2.5%) |
| Mar 2000 | - | $911.80 M(-14.7%) | $3.85 B(+1.1%) |
| Dec 1999 | $3.80 B(+14.7%) | $1.07 B(+5.4%) | $3.80 B(+6.0%) |
| Sept 1999 | - | $1.01 B(+18.9%) | $3.59 B(+3.9%) |
| June 1999 | - | $852.40 M(-1.9%) | $3.45 B(+3.4%) |
| Mar 1999 | - | $868.50 M(+1.7%) | $3.34 B(+0.8%) |
| Dec 1998 | $3.31 B(+12.4%) | $854.30 M(-2.8%) | $3.31 B(+3.9%) |
| Sept 1998 | - | $878.60 M(+18.8%) | $3.19 B(+3.7%) |
| June 1998 | - | $739.50 M(-12.2%) | $3.08 B(+2.1%) |
| Mar 1998 | - | $842.50 M(+15.5%) | $3.01 B(+2.2%) |
| Dec 1997 | $2.95 B(+13.9%) | $729.40 M(-4.6%) | $2.95 B(+1.9%) |
| Sept 1997 | - | $764.50 M(+13.0%) | $2.89 B(+3.3%) |
| June 1997 | - | $676.50 M(-13.0%) | $2.80 B(+3.7%) |
| Mar 1997 | - | $777.80 M(+15.1%) | $2.70 B(+4.5%) |
| Dec 1996 | $2.59 B(+2.1%) | $675.70 M(+0.4%) | $2.59 B(+3.5%) |
| Sept 1996 | - | $673.10 M(+16.7%) | $2.50 B(+1.0%) |
| June 1996 | - | $577.00 M(-12.8%) | $2.48 B(-0.8%) |
| Mar 1996 | - | $662.00 M(+12.5%) | $2.50 B(-1.5%) |
| Dec 1995 | $2.54 B(+13.8%) | $588.70 M(-9.2%) | $2.54 B(+13.9%) |
| Sept 1995 | - | $648.00 M(+8.4%) | $2.23 B(+5.9%) |
| June 1995 | - | $597.80 M(-14.7%) | $2.10 B(+6.2%) |
| Mar 1995 | - | $701.00 M(+151.7%) | $1.98 B(+10.2%) |
| Dec 1994 | $2.23 B(+111.9%) | $278.50 M(-46.8%) | $1.79 B(+126.9%) |
| Sept 1994 | - | $523.50 M(+10.2%) | $790.90 M(+16.2%) |
| June 1994 | - | $475.10 M(-8.2%) | $680.50 M(+2.8%) |
| Mar 1994 | - | $517.80 M(-171.4%) | $662.10 M(+1.5%) |
| Dec 1993 | $1.05 B(-31.0%) | -$725.50 M(-275.6%) | $652.60 M(-64.2%) |
| Sept 1993 | - | $413.10 M(-9.5%) | $1.82 B(+65.3%) |
| June 1993 | - | $456.70 M(-10.2%) | $1.10 B(+1.8%) |
| Mar 1993 | - | $508.30 M(+14.1%) | $1.08 B(-6.2%) |
| Dec 1992 | $1.52 B(-26.3%) | $445.30 M(-244.9%) | $1.16 B(+1.1%) |
| Sept 1992 | - | -$307.40 M(-170.3%) | $1.14 B(-38.5%) |
| June 1992 | - | $437.50 M(-24.6%) | $1.86 B(+0.4%) |
| Mar 1992 | - | $580.10 M(+33.9%) | $1.85 B(+4.8%) |
| Dec 1991 | $2.07 B(+15.7%) | $433.20 M(+5.9%) | $1.77 B(+2.8%) |
| Sept 1991 | - | $409.00 M(-5.0%) | $1.72 B(+2.5%) |
| June 1991 | - | $430.30 M(-13.2%) | $1.68 B(+4.5%) |
| Mar 1991 | - | $495.80 M(+28.7%) | $1.61 B(+4.3%) |
| Dec 1990 | $1.79 B(+28.2%) | $385.30 M(+5.2%) | $1.54 B(+12.7%) |
| Sept 1990 | - | $366.40 M(+2.5%) | $1.37 B(+9.2%) |
| June 1990 | - | $357.60 M(-16.9%) | $1.25 B(+4.7%) |
| Mar 1990 | - | $430.10 M(+103.5%) | $1.19 B(-40.0%) |
| Dec 1989 | $1.39 B(+11.5%) | $211.30 M(-15.9%) | $1.99 B(-1077.6%) |
| Sept 1989 | - | $251.20 M(-16.5%) | -$203.40 M(-141.9%) |
| June 1989 | - | $301.00 M(-75.4%) | $486.00 M(-59.5%) |
| Mar 1989 | - | $1.23 B(-161.8%) | $1.20 B(+14.6%) |
| Dec 1988 | $1.25 B(+60.5%) | -$1.98 B(-310.6%) | $1.05 B(+78.0%) |
| Sept 1988 | - | $940.60 M(-7.3%) | $588.10 M(-2.8%) |
| June 1988 | - | $1.01 B(-5.4%) | $605.20 M(-0.5%) |
| Mar 1988 | - | $1.07 B(-144.0%) | $608.10 M(+2.2%) |
| Dec 1987 | $779.30 M(-24.9%) | -$2.44 B(-354.7%) | $595.00 M(-48.0%) |
| Sept 1987 | - | $957.70 M(-5.9%) | $1.14 B(+6.9%) |
| June 1987 | - | $1.02 B(-3.9%) | $1.07 B(+14.9%) |
| Mar 1987 | - | $1.06 B(-156.0%) | $931.00 M(+8.2%) |
| Dec 1986 | $1.04 B(+15.3%) | -$1.89 B(-314.0%) | $860.30 M(-19.0%) |
| Sept 1986 | - | $883.40 M(+0.5%) | $1.06 B(+9.9%) |
| June 1986 | - | $879.30 M(-11.0%) | $966.30 M(+14.5%) |
| Mar 1986 | - | $988.30 M(-158.5%) | $843.80 M(+10.4%) |
| Dec 1985 | $900.60 M(+4.1%) | -$1.69 B(-314.4%) | $764.30 M(-11.8%) |
| Sept 1985 | - | $787.90 M(+4.1%) | $866.50 M(+9.5%) |
| June 1985 | - | $756.80 M(-16.7%) | $791.20 M(+4.3%) |
| Mar 1985 | - | $908.80 M(-157.3%) | $758.30 M(+1.9%) |
| Dec 1984 | $865.00 M | -$1.59 B(-322.7%) | $744.30 M(-68.1%) |
| Sept 1984 | - | $712.60 M(-1.6%) | $2.33 B(+44.0%) |
| June 1984 | - | $723.90 M(-19.1%) | $1.62 B(+80.9%) |
| Mar 1984 | - | $894.80 M | $894.80 M |
FAQ
- What is Eli Lilly and Company annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company annual EBITDA year-on-year change?
- What is Eli Lilly and Company quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly EBITDA year-on-year change?
- What is Eli Lilly and Company TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Eli Lilly and Company?
- What is Eli Lilly and Company TTM EBITDA year-on-year change?
What is Eli Lilly and Company annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LLY is $10.33 B
What is the all time high annual EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high annual earnings before interest, taxes, depreciation & amortization is $10.33 B
What is Eli Lilly and Company annual EBITDA year-on-year change?
Over the past year, LLY annual earnings before interest, taxes, depreciation & amortization has changed by +$1.66 B (+19.22%)
What is Eli Lilly and Company quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LLY is $2.25 B
What is the all time high quarterly EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.12 B
What is Eli Lilly and Company quarterly EBITDA year-on-year change?
Over the past year, LLY quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.29 B (+133.48%)
What is Eli Lilly and Company TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LLY is $12.51 B
What is the all time high TTM EBITDA for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM earnings before interest, taxes, depreciation & amortization is $12.51 B
What is Eli Lilly and Company TTM EBITDA year-on-year change?
Over the past year, LLY TTM earnings before interest, taxes, depreciation & amortization has changed by +$4.43 B (+54.71%)